NCT02962102View on ClinicalTrials.gov

Activated Vitamin D for the Prevention and Treatment of Acute Kidney Injury

PHASE2CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

April 3, 2017

Primary Completion Date

July 16, 2020

Study Completion Date

August 6, 2020

Conditions
Critically IllAcute Kidney Injury
Interventions
DRUG

Calcifediol

Calcifediol 400mcg orally x 1, followed by 200mcg orally daily x 4

DRUG

Calcitriol

Calcitriol 4mcg orally daily x 5

DRUG

Placebos

Placebo (medium chain triglyceride oil) orally daily x 5

Trial Locations (1)

02115

Brigham and Women's Hospital, Boston

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

David Leaf

OTHER

NCT02962102 - Activated Vitamin D for the Prevention and Treatment of Acute Kidney Injury | Biotech Hunter | Biotech Hunter